Concepedia

Viveca Nerme

VN

Statistics

Publications

17

Citations

570

H-Index

15

Active since

1984

Affiliations

AstraZeneca (Sweden)(Current)

University of Antwerp

Viveca Nerme is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and pharmacodynamics.

Publications per year

1984–2015

17

Publications

17

Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold‐dependent mechanism

Judith Leurs, Viveca Nerme, Yani Sim et al. · Journal of Thrombosis and Haemostasis · 2004 · 113 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma

Judith Leurs, Britt‐Marie Wissing, Viveca Nerme et al. · Thrombosis and Haemostasis · 2003 · 51 citations

Life Sciences, Biochemistry, Physiology +14

The Fab-fragment of a PAI-1 Inhibiting Antibody Reduces Thrombus Size and Restores Blood Flow in a Rat Model of Arterial Thrombosis

J.J.J. van Giezen, Göran Wahlund, Viveca Nerme et al. · Thrombosis and Haemostasis · 1997 · 51 citations

Medicine, Pharmacology, Pharmacotherapy +12

Creating Novel Activated Factor XI Inhibitors through Fragment Based Lead Generation and Structure Aided Drug Design

Ola Fjellström, Sibel Akkaya, Hans‐Georg Beisel et al. · PLoS ONE · 2015 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Anti-thrombotic Effect of a PAI-1 Inhibitor in Rats Given Endotoxin

Tommy Abrahamsson, Viveca Nerme, Mats Strömqvist et al. · Thrombosis and Haemostasis · 1996 · 35 citations

Medicine, Immunology, Pharmacology +13

1–5 of 17